Arginine-responsive asymptomatic hyperammonemia in the premature infant

Mark L. Batshaw, Renee C. Wachtel, George H. Thomas, Andrea Starrett, Saul W. Brusilow

Research output: Contribution to journalArticlepeer-review

Abstract

We found that more than 50% of premature infants have elevated plasma ammonium levels during the first 2 months of life. Ammonium levels were twice normal and were unaccompanied by clinical symptoms of vomiting or lethargy. Ten of these infants were given supplements of arginine (1 to 2 mmol/kg/day PO) for 1 to 2 weeks preceded and followed by control periods. In each infant, plasma ammonium levels fell significantly within 2 days of start of arginine supplementation, and increased once arginine was discontinued. We studied 59 additional premature infants, of whom 26 had normal ammonium levels and 33 were hyperammonemic. Plasma arginine and ornithine levels were significantly lower in the hyperammonemic group, but there was no difference in urinary excretion of arginine or ornithine between groups. Half of the hyperammonemic infants received arginine supplementation between 2 and 8 weeks of age. Plasma ammonium levels in the arginine group was 33+1 μmol/L, compared to 45+2 μmol/L in the untreated group. Follow-up at 18 months of age showed similar IQ scores in all groups, suggesting that significant neurologic deficits do not result from this transient metabolic defect. The mechanism of the hyperammonemia is unclear.

Original languageEnglish (US)
Pages (from-to)86-91
Number of pages6
JournalThe Journal of pediatrics
Volume105
Issue number1
DOIs
StatePublished - Jul 1984

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Arginine-responsive asymptomatic hyperammonemia in the premature infant'. Together they form a unique fingerprint.

Cite this